The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Alliance A091902: A multicenter randomized phase II trial of paclitaxel (P) with or without nivolumab (N) in patients (pts) with advanced angiosarcoma (AS).
 
Juneko E. Grilley-Olson
Consulting or Advisory Role - AADi; Sorrento Therapeutics
Research Funding - InhibRx (Inst); PTC Therapeutics (Inst)
 
Jacob B. Allred
No Relationships to Disclose
 
Scott Schuetze
Research Funding - Adaptimmune (Inst); Amgen (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Rain Therapeutics (Inst); Shanghai Pharma (Inst); TRACON Pharma (Inst)
 
Elizabeth J. Davis
Honoraria - MJH Life Sciences
Consulting or Advisory Role - Aadi; Deciphera
Speakers' Bureau - Physicans' Education Resource
Research Funding - Actuate Therapeutics (Inst); Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Incyte (Inst); InhibRx (Inst); Karyopharm Therapeutics (Inst); TopAlliance BioSciences Inc (Inst)
 
Andrew Stewart Poklepovic
Consulting or Advisory Role - Novartis
Speakers' Bureau - Natera
 
Michael J Wagner
Consulting or Advisory Role - AADi; Adaptimmune; Boehringer Ingelheim; Deciphera; Pharmaessentia
Research Funding - Adaptimmune (Inst); Athenex (Inst); Deciphera (Inst); Foghorn Therapeutics (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Presage Biosciences (Inst)
Travel, Accommodations, Expenses - Cogent Biosciences; Cogent Biosciences; Epizyme
 
Richard F. Riedel
Employment - Limbguard (I)
Leadership - Limbguard (I)
Stock and Other Ownership Interests - Limbguard (I)
Consulting or Advisory Role - AADi; Adaptimmune; Blueprint Medicines; Boehringer Ingelheim; Daiichi Sankyo; Deciphera; GlaxoSmithKline; NanoCarrier; SpringWorks Therapeutics
Research Funding - AADi (Inst); Arog (Inst); Ayala Pharmaceuticals (Inst); BioAtla (Inst); Blueprint Medicines (Inst); Cogent Biosciences (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); InhibRx (Inst); NanoCarrier (Inst); Oncternal Therapeutics (Inst); Philogen (Inst); PTC Therapeutics (Inst); SpringWorks Therapeutics (Inst); TRACON Pharma (Inst); Trillium Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - PandoNet - Limbguard (I)
Travel, Accommodations, Expenses - Daiichi Sankyo; Deciphera; NanoCarrier; SpringWorks Therapeutics
 
Alicia Hartranft
No Relationships to Disclose
 
Meng Xu WELLIVER
Consulting or Advisory Role - Lilly; Lilly; Novocure; Novocure
Travel, Accommodations, Expenses - Novocure
 
Stephanie A. Berg
Honoraria - Aptitude Health; MJH Life Sciences
Consulting or Advisory Role - Bristol Meyers Squibb; Eisai; Exelixis; Exelixis; Genzyme; Myovant Sciences; Pfizer; Seattle Genetics/Astellas
 
Suzanne George
Stock and Other Ownership Interests - Abbott Laboratories
Honoraria - CStone Pharmaceuticals
Consulting or Advisory Role - Bayer; BioAtla; Blueprint Medicines; Daiichi; deciphera; Immunicum; Kayothera; Lilly; MORE Health; Research to Practice; UpToDate
Research Funding - Acrivon Therapeutics; BioAtla; Blueprint Medicines (Inst); Daiichi Sankyo RD Novare (Inst); Deciphera (Inst); Eisai (Inst); IDRx (Inst); Merck (Inst); NewBay Pharma (Inst); SpringWorks Therapeutics (Inst); Theseus Pharmaceuticals (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - UptoDate
Expert Testimony - Bayer
Other Relationship - Research to Practice; WCG
 
Steven Ian Robinson
Honoraria - AADi (Inst); BTG (Inst); HMP; Intellisphere (Inst); Medpace (Inst); TRACON Pharma (Inst)
Consulting or Advisory Role - AADi (Inst); BTG (Inst); Medpace (Inst); TRACON Pharma (Inst)
Research Funding - TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Cogent Biosciences (Inst); GlaxoSmithKline (Inst); Society of Interventional Radiology Foundation (Inst); TRACON Pharma (Inst)
 
Paul B. Googe
No Relationships to Disclose
 
Sandra P. D'Angelo
Honoraria - AADi; Adaptimmune; GI Innovation; GlaxoSmithKline; Incyte; Nektar; Pfizer; Rain Therapeutics; SERVIER
Consulting or Advisory Role - AADi; Adaptimmune; GI Innovation; GlaxoSmithKline; Incyte; Nektar; Pfizer; Rain Therapeutics; Servier
Research Funding - Amgen; Bristol-Myers Squibb.; Deciphera; EMD Serono; Incyte; Merck; Nektar
Travel, Accommodations, Expenses - Adaptimmune; EMD Serono; Nektar
Other Relationship - Adaptimmune; GlaxoSmithKline; Merck; Nektar
 
Gary K. Schwartz
Stock and Other Ownership Interests - Bionaut Labs; GenCirq; January Therapeutics
Consulting or Advisory Role - AADi; Agenus; Astex Pharmaceuticals; Bionaut Labs; Boehringer Ingelheim; Concarlo; Gencirq; Ipsen; January Therapeutics; Kirilys Therapeutics; Oncogenuity; OnCusp Therapeutics; PureTech; Shanghai Pharma
Research Funding - Astex Pharmaceuticals; Oxford BioTherapeutics (Inst); PTC Therapeutics (Inst); Rain Therapeutics (Inst); SpringWorks Therapeutics (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Companion diagnostics for CD4 inhibitors (Inst); patent granted to develop a new technology called PNAs for cancer therapy
Travel, Accommodations, Expenses - Boehringer Ingelheim